Synthesis and Antiproliferative Activity against Melanoma Cells of New Heterocyclic Hybrids Based on Pyridine and Pyrimidine Scaffolds.

IF 3.5 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Magdalena Perużyńska, Radosław Birger, Tomasz J Idzik, Zofia M Myk, Magdalena M Lubowicz, Łukasz Struk, Jacek G Sośnicki, Patrycja Kłos, Dariusz Chlubek, Marek Droździk
{"title":"Synthesis and Antiproliferative Activity against Melanoma Cells of New Heterocyclic Hybrids Based on Pyridine and Pyrimidine Scaffolds.","authors":"Magdalena Perużyńska, Radosław Birger, Tomasz J Idzik, Zofia M Myk, Magdalena M Lubowicz, Łukasz Struk, Jacek G Sośnicki, Patrycja Kłos, Dariusz Chlubek, Marek Droździk","doi":"10.2174/0109298673370617250330151330","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Over 85% of biologically active compounds are heterocycles or contain heterocyclic groups, underscoring their vital importance in contemporary drug development. Among them, nitrogen-containing derivatives, such as pyridines and pyrimidines, are considered privileged structures in approved drugs or are extensively studied due to their promising therapeutic effects.</p><p><strong>Objective: </strong>In the current work, we would like to verify the hypothesis that incorporating heterocyclic pharmacophores into derivatives of pyrimidine-2(1H)-thione (PMT), 2-pyridone (P), pyridine-2(1H)-thione (PT), dihydropyrimidine-2(1H)-thione (DHPMT), dihydropyridin- 2(1H)-one (DHP), and dihydropyridine-2(1H)-thione (DHPT) rings enhances antitumor activity.</p><p><strong>Methods: </strong>A range of novel pyridine- and pyrimidine-based compounds were synthesized and assessed for their anticancer properties against the melanoma A375 cell line. The two most potent compounds (16b and 29) were then chosen for further evaluation of their effects on non-cancerous human dermal fibroblasts, cancer cell apoptosis, cell cycle phase distribution, and tubulin polymerization. Furthermore, in silico analyses were performed to assess the pharmacokinetics, toxicity, drug-likeness, and molecular target of the selected compounds.</p><p><strong>Results: </strong>Among the 33 compounds tested, pyridine analogs 16b and 29 demonstrated the strongest antiproliferative activity (with IC50 values of 1.85 ± 0.44 μM and 4.85 ± 1.67 μM, respectively) and selectivity (SI=65.08 and SI> 100, respectively) against cancer cells. Additional studies revealed that compound 16b, which features a thiophene ring at the C-5 position and a 3,4,5-trimethoxyphenyl (TMP) group, showed the most promising cell cycle arrest and tubulin polymerization inhibition (IC50=37.26 ± 10.86 μM), resulting in cancer cell apoptosis. In silico ADMET analysis confirmed the drug-- likeness of the synthesized compounds.</p><p><strong>Conclusion: </strong>This research reinforced the significance of heterocyclic rings as valuable pharmacophores. Additionally, it highlighted the antiproliferative and antimitotic potential of modified pyridine derivatives.</p>","PeriodicalId":10984,"journal":{"name":"Current medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0109298673370617250330151330","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Over 85% of biologically active compounds are heterocycles or contain heterocyclic groups, underscoring their vital importance in contemporary drug development. Among them, nitrogen-containing derivatives, such as pyridines and pyrimidines, are considered privileged structures in approved drugs or are extensively studied due to their promising therapeutic effects.

Objective: In the current work, we would like to verify the hypothesis that incorporating heterocyclic pharmacophores into derivatives of pyrimidine-2(1H)-thione (PMT), 2-pyridone (P), pyridine-2(1H)-thione (PT), dihydropyrimidine-2(1H)-thione (DHPMT), dihydropyridin- 2(1H)-one (DHP), and dihydropyridine-2(1H)-thione (DHPT) rings enhances antitumor activity.

Methods: A range of novel pyridine- and pyrimidine-based compounds were synthesized and assessed for their anticancer properties against the melanoma A375 cell line. The two most potent compounds (16b and 29) were then chosen for further evaluation of their effects on non-cancerous human dermal fibroblasts, cancer cell apoptosis, cell cycle phase distribution, and tubulin polymerization. Furthermore, in silico analyses were performed to assess the pharmacokinetics, toxicity, drug-likeness, and molecular target of the selected compounds.

Results: Among the 33 compounds tested, pyridine analogs 16b and 29 demonstrated the strongest antiproliferative activity (with IC50 values of 1.85 ± 0.44 μM and 4.85 ± 1.67 μM, respectively) and selectivity (SI=65.08 and SI> 100, respectively) against cancer cells. Additional studies revealed that compound 16b, which features a thiophene ring at the C-5 position and a 3,4,5-trimethoxyphenyl (TMP) group, showed the most promising cell cycle arrest and tubulin polymerization inhibition (IC50=37.26 ± 10.86 μM), resulting in cancer cell apoptosis. In silico ADMET analysis confirmed the drug-- likeness of the synthesized compounds.

Conclusion: This research reinforced the significance of heterocyclic rings as valuable pharmacophores. Additionally, it highlighted the antiproliferative and antimitotic potential of modified pyridine derivatives.

基于吡啶和嘧啶支架的新型杂环杂环化合物的合成及其对黑色素瘤细胞的抗增殖活性。
背景:超过85%的生物活性化合物是杂环或含有杂环基团,强调了它们在当代药物开发中的重要性。其中,含氮衍生物,如吡啶和嘧啶,被认为是批准药物中的特权结构或因其具有良好的治疗效果而被广泛研究。目的:验证杂环药物载体在嘧啶-2(1H)-硫酮(PMT)、2-吡啶酮(P)、吡啶-2(1H)-硫酮(PT)、二氢嘧啶-2(1H)-硫酮(DHPMT)、二氢吡啶-2(1H)- one (DHP)和二氢吡啶-2(1H)-硫酮(DHPT)环衍生物中加入能增强抗肿瘤活性的假设。方法:合成了一系列新的吡啶和嘧啶基化合物,并评估了它们对黑色素瘤A375细胞系的抗癌特性。然后选择两种最有效的化合物(16b和29)进一步评估其对非癌性人真皮成纤维细胞、癌细胞凋亡、细胞周期期分布和微管蛋白聚合的影响。此外,进行了计算机分析,以评估所选化合物的药代动力学、毒性、药物相似性和分子靶点。结果:在33个化合物中,吡啶类似物16b和29对肿瘤细胞的抑制活性最强(IC50分别为1.85±0.44 μM和4.85±1.67 μM),选择性最强(SI分别为65.08和bbb100)。进一步的研究表明,化合物16b在C-5位置有一个噻吩环和一个3,4,5-三甲氧基(TMP)基团,具有抑制肿瘤细胞周期和微管蛋白聚合的作用(IC50=37.26±10.86 μM),导致肿瘤细胞凋亡。计算机ADMET分析证实了合成化合物的药物相似性。结论:本研究强化了杂环作为有价值的药效团的意义。此外,它强调了修饰吡啶衍生物的抗增殖和抗有丝分裂潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current medicinal chemistry
Current medicinal chemistry 医学-生化与分子生物学
CiteScore
8.60
自引率
2.40%
发文量
468
审稿时长
3 months
期刊介绍: Aims & Scope Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信